iGlarLixi vs IDegAsp in Chinese Participants After OAD(s)

Clinical trial NCT05413369 · COMPLETED

Trial details

NCT number: NCT05413369
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus

Start date: 2022-07-07
Primary completion: 2023-10-20
Enrollment: 582

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.